Telomir Pharmaceuticals, Common Stock Price History
| TELO Stock | 4.15 0.19 4.38% |
If you're considering investing in Telomir Stock, it is important to understand the factors that can impact its price. As of today, the current price of Telomir Pharmaceuticals, stands at 4.15, as last reported on the 26th of March, with the highest price reaching 4.15 and the lowest price hitting 4.15 during the day. Telomir Pharmaceuticals, owns Efficiency Ratio (i.e., Sharpe Ratio) of close to zero, which indicates the firm had a close to zero % return per unit of risk over the last 3 months. Telomir Pharmaceuticals, Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Telomir Pharmaceuticals,'s Risk Adjusted Performance of 0.0066, variance of 35.15, and Coefficient Of Variation of (42,097) to confirm the risk estimate we provide.
At this time, Telomir Pharmaceuticals,'s Total Stockholder Equity is very stable compared to the past year. As of the 26th of March 2025, Other Stockholder Equity is likely to grow to about 37.7 M, while Common Stock Shares Outstanding is likely to drop about 23.7 M. . At this time, Telomir Pharmaceuticals,'s Price Book Value Ratio is very stable compared to the past year. As of the 26th of March 2025, Price To Book Ratio is likely to grow to 198.72, while Price Earnings Ratio is likely to drop (7.73). Telomir Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Telomir |
Sharpe Ratio = -0.0022
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TELO |
Estimated Market Risk
| 5.67 actual daily | 50 50% of assets are less volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Telomir Pharmaceuticals, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Telomir Pharmaceuticals, by adding Telomir Pharmaceuticals, to a well-diversified portfolio.
Telomir Pharmaceuticals, Stock Price History Chart
There are several ways to analyze Telomir Stock price data. The simplest method is using a basic Telomir candlestick price chart, which shows Telomir Pharmaceuticals, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 24, 2025 | 5.03 |
| Lowest Price | February 21, 2025 | 3.91 |
Telomir Pharmaceuticals, March 26, 2025 Stock Price Synopsis
Various analyses of Telomir Pharmaceuticals,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Telomir Stock. It can be used to describe the percentage change in the price of Telomir Pharmaceuticals, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Telomir Stock.| Telomir Pharmaceuticals, Price Action Indicator | (0.09) | |
| Telomir Pharmaceuticals, Price Rate Of Daily Change | 0.96 |
Telomir Pharmaceuticals, March 26, 2025 Stock Price Analysis
Telomir Stock Price History Data
The price series of Telomir Pharmaceuticals, for the period between Thu, Dec 26, 2024 and Wed, Mar 26, 2025 has a statistical range of 1.27 with a coefficient of variation of 7.18. The price distribution for the period has arithmetic mean of 4.46. The median price for the last 90 days is 4.51.| Open | High | Low | Close | Volume | ||
03/26/2025 | 4.34 | 4.15 | 4.15 | 4.15 | ||
| 03/25/2025 | 4.51 | 4.54 | 4.26 | 4.34 | 114,808 | |
| 03/24/2025 | 4.35 | 4.81 | 4.35 | 4.53 | 224,983 | |
| 03/21/2025 | 4.06 | 4.61 | 3.90 | 4.56 | 650,438 | |
| 03/20/2025 | 4.35 | 4.54 | 4.06 | 4.08 | 80,942 | |
| 03/19/2025 | 4.20 | 4.44 | 4.09 | 4.35 | 109,929 | |
| 03/18/2025 | 4.12 | 4.57 | 3.91 | 4.12 | 150,794 | |
| 03/17/2025 | 4.53 | 4.83 | 4.14 | 4.17 | 118,034 | |
| 03/14/2025 | 5.10 | 5.23 | 4.50 | 4.58 | 304,608 | |
| 03/13/2025 | 4.77 | 5.40 | 4.76 | 5.03 | 198,377 | |
| 03/12/2025 | 4.49 | 4.97 | 4.36 | 4.94 | 103,033 | |
| 03/11/2025 | 4.23 | 4.60 | 4.13 | 4.54 | 122,180 | |
| 03/10/2025 | 4.17 | 4.43 | 4.04 | 4.23 | 106,841 | |
| 03/07/2025 | 4.16 | 4.48 | 4.05 | 4.35 | 130,076 | |
| 03/06/2025 | 4.07 | 4.15 | 4.03 | 4.14 | 46,872 | |
| 03/05/2025 | 4.09 | 4.44 | 4.01 | 4.13 | 146,951 | |
| 03/04/2025 | 4.11 | 4.28 | 3.80 | 4.05 | 393,618 | |
| 03/03/2025 | 4.05 | 4.18 | 4.01 | 4.11 | 130,615 | |
| 02/28/2025 | 3.90 | 4.05 | 3.88 | 4.00 | 69,252 | |
| 02/27/2025 | 4.13 | 4.19 | 3.90 | 3.91 | 101,841 | |
| 02/26/2025 | 4.16 | 4.18 | 4.07 | 4.12 | 47,634 | |
| 02/25/2025 | 4.25 | 4.35 | 3.92 | 4.15 | 121,300 | |
| 02/24/2025 | 4.00 | 4.44 | 4.00 | 4.24 | 268,067 | |
| 02/21/2025 | 4.21 | 4.34 | 3.90 | 3.91 | 145,877 | |
| 02/20/2025 | 4.09 | 4.25 | 4.09 | 4.18 | 60,600 | |
| 02/19/2025 | 3.90 | 4.22 | 3.75 | 4.21 | 105,872 | |
| 02/18/2025 | 4.16 | 4.18 | 3.86 | 3.92 | 334,812 | |
| 02/14/2025 | 4.25 | 4.30 | 4.17 | 4.29 | 53,656 | |
| 02/13/2025 | 4.27 | 4.32 | 4.22 | 4.27 | 51,500 | |
| 02/12/2025 | 4.35 | 4.48 | 4.18 | 4.25 | 210,793 | |
| 02/11/2025 | 4.44 | 4.52 | 4.35 | 4.37 | 78,616 | |
| 02/10/2025 | 4.37 | 4.64 | 4.37 | 4.47 | 66,563 | |
| 02/07/2025 | 4.51 | 4.65 | 4.32 | 4.37 | 166,451 | |
| 02/06/2025 | 4.68 | 4.83 | 4.50 | 4.52 | 69,398 | |
| 02/05/2025 | 4.50 | 4.66 | 4.50 | 4.65 | 77,298 | |
| 02/04/2025 | 4.17 | 4.62 | 4.17 | 4.51 | 128,300 | |
| 02/03/2025 | 4.85 | 4.98 | 4.14 | 4.17 | 384,800 | |
| 01/31/2025 | 4.54 | 5.02 | 4.54 | 4.86 | 125,200 | |
| 01/30/2025 | 4.56 | 4.65 | 4.51 | 4.52 | 41,600 | |
| 01/29/2025 | 4.70 | 4.80 | 4.50 | 4.51 | 92,100 | |
| 01/28/2025 | 4.70 | 4.88 | 4.56 | 4.64 | 123,500 | |
| 01/27/2025 | 4.79 | 5.00 | 4.67 | 4.75 | 53,800 | |
| 01/24/2025 | 4.85 | 5.08 | 4.67 | 5.03 | 70,800 | |
| 01/23/2025 | 4.95 | 5.01 | 4.67 | 4.75 | 53,700 | |
| 01/22/2025 | 4.94 | 5.15 | 4.83 | 4.98 | 72,200 | |
| 01/21/2025 | 4.70 | 5.00 | 4.62 | 4.93 | 63,700 | |
| 01/17/2025 | 4.83 | 4.94 | 4.61 | 4.69 | 48,900 | |
| 01/16/2025 | 4.84 | 5.17 | 4.73 | 4.79 | 78,300 | |
| 01/15/2025 | 4.63 | 4.90 | 4.55 | 4.84 | 90,800 | |
| 01/14/2025 | 4.70 | 4.70 | 4.41 | 4.58 | 44,200 | |
| 01/13/2025 | 4.20 | 4.86 | 4.14 | 4.50 | 223,500 | |
| 01/10/2025 | 4.28 | 4.48 | 4.05 | 4.11 | 226,300 | |
| 01/08/2025 | 4.36 | 4.58 | 4.28 | 4.30 | 91,300 | |
| 01/07/2025 | 4.50 | 4.86 | 4.33 | 4.55 | 187,100 | |
| 01/06/2025 | 4.47 | 4.62 | 4.23 | 4.23 | 126,700 | |
| 01/03/2025 | 4.08 | 4.66 | 4.04 | 4.52 | 103,900 | |
| 01/02/2025 | 4.11 | 4.35 | 4.01 | 4.07 | 85,000 | |
| 12/31/2024 | 4.77 | 4.77 | 4.02 | 4.12 | 286,000 | |
| 12/30/2024 | 4.75 | 4.82 | 4.50 | 4.64 | 145,800 | |
| 12/27/2024 | 4.72 | 5.11 | 4.66 | 4.87 | 207,300 | |
| 12/26/2024 | 4.97 | 5.16 | 4.68 | 4.81 | 83,700 |
About Telomir Pharmaceuticals, Stock history
Telomir Pharmaceuticals, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Telomir is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Telomir Pharmaceuticals, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Telomir Pharmaceuticals, stock prices may prove useful in developing a viable investing in Telomir Pharmaceuticals,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.6 M | 23.7 M |
Telomir Pharmaceuticals, Stock Technical Analysis
Telomir Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Telomir Pharmaceuticals, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Telomir Pharmaceuticals,'s price direction in advance. Along with the technical and fundamental analysis of Telomir Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Telomir to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0066 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.04) | |||
| Treynor Ratio | (0.04) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.